151 related articles for article (PubMed ID: 35332788)
1. Analysis of a panel-based pharmacogenomics testing program among members of a commercial and Medicare client of a pharmacy benefits manager.
Steinbach M; Wickizer M; Siwak A; Patel T; Olson J; Horowitz S; Topp R
J Manag Care Spec Pharm; 2022 Apr; 28(4):485-490. PubMed ID: 35332788
[No Abstract] [Full Text] [Related]
2. Applications for pharmacogenomics in pharmacy practice: A scoping review.
Hayashi M; Hamdy DA; Mahmoud SH
Res Social Adm Pharm; 2022 Jul; 18(7):3094-3118. PubMed ID: 34474980
[TBL] [Abstract][Full Text] [Related]
3. Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting.
Brown LC; Lorenz RA; Li J; Dechairo BM
Clin Ther; 2017 Mar; 39(3):592-602.e1. PubMed ID: 28238356
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation.
Winner JG; Carhart JM; Altar CA; Goldfarb S; Allen JD; Lavezzari G; Parsons KK; Marshak AG; Garavaglia S; Dechairo BM
Curr Med Res Opin; 2015; 31(9):1633-43. PubMed ID: 26086890
[TBL] [Abstract][Full Text] [Related]
5. Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data.
Rivers ZT; Parsons HM; Jacobson PA; Kuntz KM; Farley JF; Stenehjem DJ
Pharmacogenomics J; 2022 May; 22(3):198-209. PubMed ID: 35361994
[TBL] [Abstract][Full Text] [Related]
6. Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
Kim K; Magness JW; Nelson R; Baron V; Brixner DI
J Manag Care Spec Pharm; 2018 Dec; 24(12):1250-1259. PubMed ID: 30479202
[TBL] [Abstract][Full Text] [Related]
7. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review.
Socco S; Wake DT; Lee JC; Dunnenberger HM
Pharmacogenomics; 2022 Nov; 23(17):933-948. PubMed ID: 36326000
[TBL] [Abstract][Full Text] [Related]
9. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
[No Abstract] [Full Text] [Related]
10. Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing?
Chambal M; Forsthoffer C; Egnaczyk A; Seitz M; Grande K; Ashcraft K; Wick JA; Blaxall BC
J Am Pharm Assoc (2003); 2023; 63(3):939-945. PubMed ID: 37024375
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives.
Bhatt M; Peshkin BN; Kazi S; Schwartz MD; Ashai N; Swain SM; Smith DM
Pharmacogenomics; 2023 Nov; 24(16):859-870. PubMed ID: 37942634
[No Abstract] [Full Text] [Related]
12. Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation.
Bright D; Saadeh C; DeVuyst-Miller S; Sohn M; Choker A; Langerveld A
Pharmgenomics Pers Med; 2020; 13():719-724. PubMed ID: 33328756
[TBL] [Abstract][Full Text] [Related]
13. Implementing comprehensive pharmacogenomics in a community hospital-associated primary care setting.
Wick JA; Schmidlen T; Grande K; Moretz C; Ashcraft K; Green J; Moyer N; Blaxall BC
J Am Pharm Assoc (2003); 2023; 63(1):188-192. PubMed ID: 36243653
[TBL] [Abstract][Full Text] [Related]
14. Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study.
Tagwerker C; Carias-Marines MJ; Smith DJ
JMIRx Med; 2022 May; 3(2):e32902. PubMed ID: 37725552
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist-Provided Pharmacogenetic Point-of-Care Testing Consultation Service: A Time and Motion Study.
Bright DR; Klepser ME; Murry L; Klepser DG
J Pharm Technol; 2018 Aug; 34(4):139-143. PubMed ID: 34860961
[No Abstract] [Full Text] [Related]
16. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Del Toro-Pagán NM; Matos A; Thacker D; Turgeon J; Amin NS; Michaud V
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577878
[TBL] [Abstract][Full Text] [Related]
17. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
[TBL] [Abstract][Full Text] [Related]
18. Integration of a pharmacist-led pharmacogenomic service in a geriatric clinic: Barriers and outcomes.
Kehr AM; Ayers G; Saxena S; Hashmi AZ; Erwin AL; Azene A; Hockings JK
J Am Pharm Assoc (2003); 2023; 63(3):778-784. PubMed ID: 36774236
[TBL] [Abstract][Full Text] [Related]
19. Pre-emptive pharmacogenomics implementation among polypharmacy patients 65 years old and older: a clinical pilot.
Uber R; Hayduk VA; Pradhan A; Ward T; Flango A; Graham J; Wright EA
Pharmacogenomics; 2023 Dec; 24(18):915-920. PubMed ID: 37965783
[No Abstract] [Full Text] [Related]
20. Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service.
Jeiziner C; Meyer Zu Schwabedissen HE; Hersberger KE; Allemann SS
Int J Clin Pharm; 2023 Dec; 45(6):1378-1386. PubMed ID: 37338707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
